{
  "symbol": "MXCT",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["small-cap tech", "biotech sector", "low institutional ownership"],
    "riskScore": 7,
    "reason": "MaxCyte operates in the biotech sector with a focus on next-generation cell therapies, making it prone to hype. Its small market cap and presence in a speculative industry increase its susceptibility to retail-driven price movements."
  }
}